Bei-Ching Chuang

Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer

Steven Langston, Stephen Grossman, Dylan B. England et al. · Journal of Medicinal Chemistry · 2021 · 208 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +11

Sulfasalazine in ionic liquid form with improved solubility and exposure

Mohammad Shadid, Gabriela Gurău, Julia L. Shamshina et al. · MedChemComm · 2015 · 82 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Design of proteasome inhibitors with oral efficacy in vivo against <i>Plasmodium falciparum</i> and selectivity over the human proteasome

Stanley C. Xie, Riley D. Metcalfe, Hirotake Mizutani et al. · Proceedings of the National Academy of Sciences · 2021 · 37 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

Utilizing In Vitro Dissolution-Permeation Chamber for the Quantitative Prediction of pH-Dependent Drug-Drug Interactions with Acid-Reducing Agents: a Comparison with Physiologically Based Pharmacokinetic Modeling

Andy Z. X. Zhu, Ming-Chih David Ho, Christopher Gemski et al. · The AAPS Journal · 2016 · 27 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +17

Inhibition of Hepatic Organic Anion-Transporting Polypeptide by RNA Interference in Sandwich-Cultured Human Hepatocytes: An In Vitro Model to Assess Transporter-Mediated Drug-Drug Interactions

Mingxiang Liao, Arek Raczynski, Michael Chen et al. · Drug Metabolism and Disposition · 2010 · 18 citations

Pharmacy, Biochemistry, Pharmacology +17